Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  11:39 2022-09-26 am EDT
16.18 EUR   -0.76%
09/16European ADRs Move Lower in Friday Trading
MT
09/16Philips showcases clinical data and solutions designed to deliver better cardiac care with greater efficiency at TCT 2022
GL
09/16Philips showcases clinical data and solutions designed to deliver better cardiac care with greater efficiency at TCT 2022
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PHILIPS NV : UBS reiterates its Sell rating

08/16/2022 | 07:12am EDT

UBS's analyst Graham Doyle maintains his Sell rating on the stock. The target price is unchanged at EUR 16.


© MarketScreener with dpa-AFX Analyser 2022
All news about PHILIPS NV
09/16European ADRs Move Lower in Friday Trading
MT
09/16Philips showcases clinical data and solutions designed to deliver better cardiac care w..
GL
09/16Philips showcases clinical data and solutions designed to deliver better cardiac care w..
AQ
09/16Royal Philips Showcases Clinical Data and Solutions Designed to Deliver Better Cardiac ..
CI
09/15European ADRs Move Lower in Thursday Trading
MT
09/15Philips highlights FetView cloud-based image sharing and reporting software for obstetr..
GL
09/15Philips highlights FetView cloud-based image sharing and reporting software for obstetr..
AQ
09/15Philips Highlights Fetview Cloud-Based Image Sharing and Reporting Software for Obstetr..
CI
09/13Philips Foundation and RAD-AID International embark on a multi-year cross-continental p..
GL
09/13Philips Foundation and RAD-AID International embark on a multi-year cross-continental p..
AQ
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 18 191 M 17 549 M 17 549 M
Net income 2022 546 M 526 M 526 M
Net Debt 2022 4 454 M 4 297 M 4 297 M
P/E ratio 2022 30,5x
Yield 2022 4,42%
Capitalization 14 225 M 13 723 M 13 723 M
EV / Sales 2022 1,03x
EV / Sales 2023 0,94x
Nbr of Employees 78 831
Free-Float 99,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 16,18 €
Average target price 24,25 €
Spread / Average Target 49,9%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Shez Partovi Chief Medical, Innovation & Strategy Officer
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-50.63%13 937
THERMO FISHER SCIENTIFIC-21.95%204 040
DANAHER CORPORATION-19.37%192 969
INTUITIVE SURGICAL, INC.-46.97%68 037
BOSTON SCIENTIFIC CORPORATION-8.43%55 690
EDWARDS LIFESCIENCES CORPORATION-34.59%52 534